How many days should Eliquis (apixaban) be held before tooth extraction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Apixaban (Eliquis) Before Tooth Extraction

For tooth extraction, which is considered a minor dental procedure with minimal bleeding risk, apixaban should NOT be discontinued as per the American College of Chest Physicians guidelines. 1

Evidence-Based Recommendations

The most recent guidelines from the American College of Chest Physicians (2022) specifically classify minor dental procedures, including dental extractions, as minimal bleeding risk procedures that do not require discontinuation of apixaban 1. This represents a significant update from older recommendations that suggested longer discontinuation periods.

For these procedures:

  • Continue apixaban without interruption
  • Implement local hemostatic measures (such as tranexamic acid mouthwash)
  • Monitor for bleeding every 30 minutes initially after the procedure

Alternative Approach (If Discontinuation Is Deemed Necessary)

If the clinician determines that discontinuation is necessary due to specific patient factors or more complex extractions, the FDA label and French Working Group on Perioperative Hemostasis (GIHP) guidelines provide the following recommendations:

  • For low bleeding risk procedures: Discontinue apixaban at least 24 hours before the procedure 2
  • For moderate to high bleeding risk procedures: Discontinue apixaban at least 48 hours before the procedure 2

For twice-daily dosing regimen of apixaban:

  • Last intake should be on the morning of the day before the planned procedure 3
  • Resume apixaban at least 6 hours after the procedure if there is no ongoing bleeding 3

Post-Extraction Management

If continuing apixaban during the extraction:

  1. Apply local hemostatic measures (gelatin sponge, suturing as needed)
  2. Consider tranexamic acid mouthwash (10 mL of 5% solution)
  3. Monitor for bleeding every 30 minutes initially
  4. Provide pressure pack with gauze for 1 hour post-extraction
  5. Avoid strenuous physical activities for 48 hours after the procedure

Important Considerations

  • Bridging anticoagulation is not recommended when temporarily discontinuing apixaban 3, 1
  • Multiple studies have shown that dental extractions can be safely performed without discontinuation of antiplatelet therapy with appropriate local hemostasis 4, 5
  • The risk of thromboembolic events from discontinuing anticoagulation may outweigh the risk of bleeding during minor dental procedures 1

Special Populations

  • For patients with renal impairment (CrCl 30-50 mL/min), if discontinuation is chosen, consider extending the discontinuation period 1
  • For patients over 80 years old, careful monitoring is required due to increased bleeding risk and potentially reduced renal function affecting drug clearance 1

Resumption of Apixaban

If apixaban was discontinued:

  • Resume at least 6 hours after the procedure if adequate hemostasis has been established 3
  • For twice daily regimen: Resume the evening of the same day 3
  • For once daily regimen with morning intake: Resume the next morning 3
  • For once daily regimen with evening intake: Resume the evening of the procedure day 3

The evidence strongly supports continuing apixaban for tooth extractions with appropriate local hemostatic measures rather than discontinuing it and risking thromboembolic events.

References

Guideline

Cataract Surgery and Anticoagulation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of bleeding following dental extraction in patients on long-term antiplatelet therapy: A clinical trial.

Indian journal of dental research : official publication of Indian Society for Dental Research, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.